(INNS)
VENSOBAFUSP ALFA(INNC)
HUMANIZED IMMUNOGLOBULIN G4-KAPPA, ANTI-(HUMAN COMPLEMENT FACTOR C5) ENGINEERED HEAVY CHAIN VARIANT (S^233>P, M^433>L, N^439>A), FUSED AT THE C-TERMINUS OF THE HEAVY CHAIN (1-452) TO A HUMAN COMPLEMENT FACTOR H (CFH, H FACTOR 1, HF1) FUNCTIONAL DOMAIN FRAGMENT (1-306, 453-758 IN THE CURRENT SEQUENCE), VARIANT (V^44>I^496), DISULFIDE BRIDGED DIMER , PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA; HUMANIZED MONOCLONAL ANTIBODY FUSION WITH HUMAN COMPLEMENT FACTOR H; TYPE: IGG4-KAPPA; ANTIGEN: HUMAN COMPLEMENT C5, CPAMD4 (C5); CDR SOURCE: MUS MUSCULUS (HUMANIZED BY CDR GRAFTING), PROPOSED INN: LIST 128, RECOMMENDED INN: LIST 90(WHO)
VENSOBAFUSPUM ALFA(INN)